Package 0173-0947-55

Brand: wellbutrin sr

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0173-0947-55
Digits Only 0173094755
Product NDC 0173-0947
Description

60 TABLET, FILM COATED in 1 BOTTLE (0173-0947-55)

Marketing

Marketing Status
Marketed Since 1996-11-15
Brand wellbutrin sr
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d1f06b35-e63d-49dc-a05d-9546f61776aa", "openfda": {"upc": ["0301730722003", "0301730135551", "0301730947550"], "unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993511", "993518", "993528", "993536", "993537"], "spl_set_id": ["cbc8c074-f080-4489-a5ae-207b5fadeba3"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (0173-0947-55)", "package_ndc": "0173-0947-55", "marketing_start_date": "19961115"}], "brand_name": "WELLBUTRIN SR", "product_id": "0173-0947_d1f06b35-e63d-49dc-a05d-9546f61776aa", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0173-0947", "generic_name": "bupropion hydrochloride", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "WELLBUTRIN", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "NDA020358", "marketing_category": "NDA", "marketing_start_date": "19961115", "listing_expiration_date": "20261231"}